Scientists develop new monoclonal antibody to treat HER2-positive breast cancer
In a step forward for breast cancer treatment, researchers at Tohoku University have developed a novel monoclonal antibody that specifically targets a certain type of breast cancer cell. Their findings, published in the International ...
Feb 19, 2024
0
0